International Flavors & Fragrances (IFF) is undergoing a significant reshaping of its portfolio, led by deductions and acquisitions in quick succession. The company's recent launch of PureStrong, a pet probiotic, indicates expansion into the pet health sector. Critically, IFF has secured the first heart health claim for soy protein in Australia and New Zealand, signalling a potentially significant market edge. Investments in the company have shifted somewhat unpredictably, with various advisory groups increasing, decreasing, and establishing new holdings in IFF. Despite a net loss due to a US$1.15B write-down in the last full fiscal year, the company witnessed a rebound in share prices. An antitrust probe ongoing in India may impact the company's fortunes, but there is continued excitement in the market about IFF's affirmed $0.40 dividend and its growth potential. Currently, analysts view the company's valuation as mixed, raising questions around its elevated costs and the impact on demand. Recent share fluctuations and rumours of staff poaching raise challenges to IFF’s public image. Nevertheless, the company's ongoing structural alterations are positioning IFF for a more focused future.
International Flavors Fragrances IFF News Analytics from Mon, 08 Sep 2025 07:00:00 GMT to Sat, 04 Apr 2026 14:07:43 GMT -
Rating 2
- Innovation 4
- Information 3
- Rumor -2
